Aspiration Pneumonia / Pneumonitis

Aspiration of oropharyngeal or gastric contents into the lower respiratory tract — pneumonitis (chemical) vs. pneumonia (bacterial); risk factors include dysphagia, AMS, alcohol, stroke, and dementia

Symptoms / Associated Sx

• Sudden dyspnea or cough following aspiration event (witnessed or suspected)

• Fever, tachycardia, tachypnea

• Cough — productive or non-productive

• Hypoxia (proportional to volume and acidity of aspirated material)

• Crackles in dependent lung segments (right lower lobe most common; right middle lobe in upright position)

• Dysphagia, coughing/choking with meals, silent aspiration (recurrent pneumonias)

Denies

• Community exposure without aspiration risk factors (raises classic CAP over aspiration)

• Normal swallow function and mentation (reduces aspiration likelihood)

• Non-dependent lobe involvement (upper lobes suggest TB or other pathogen; dependent segments = aspiration)

Social History (SHx)

Stroke (dysphagia — most common etiology), dementia (impaired swallow reflex), alcohol intoxication, seizure, general anesthesia, sedating medications, GERD, prior aspiration events, nursing home or LTC residence, intubation (ventilator-associated aspiration), esophageal motility disorders, poor dentition (anaerobic bacteria burden).

Main Etiology

• Aspiration pneumonitis (Mendelson's syndrome): Chemical injury from gastric acid aspiration; sterile; self-limited; no antibiotics needed unless superinfection develops (pH <2.5 is most injurious)

• Aspiration pneumonia: Bacterial infection from aspirated oropharyngeal flora; anaerobes (Bacteroides, Fusobacterium, Prevotella), Streptococcus, gram-negatives in healthcare-associated

• Healthcare/nursing home-associated: gram-negative rods (Klebsiella, E. coli), MRSA, Pseudomonas in high-risk

Most Common DDx

• Community-acquired pneumonia — no aspiration risk (typical bacterial; no dependent lobe predominance; community exposure; lobar consolidation; responds to standard CAP antibiotics)

• CHF with pulmonary edema (bilateral symmetric infiltrates; BNP elevated; no aspiration event; responds to diuretics)

• Lung abscess (cavitary infiltrate in dependent segment; anaerobes; constitutional symptoms; fever persisting >1 week; foul-smelling sputum)

• ARDS from aspiration (bilateral diffuse infiltrates within 24–48h of massive aspiration; P/F <300; requires mechanical ventilation support)

• Bronchial obstruction from foreign body (unilateral hyperinflation; sudden onset; bronchoscopy)

• Empyema complicating aspiration (pleural effusion + fever + consolidation; pH <7.2 on thoracentesis; chest tube required)

DATA

• CBC (leukocytosis → bacterial pneumonia; may be absent in elderly/immunosuppressed)

• BMP (creatinine; glucose — aspiration risk in diabetics with gastroparesis)

• Procalcitonin (guides antibiotic need; elevated in bacterial pneumonia; low in pure pneumonitis)

• Blood cultures × 2 (before antibiotics; bacteremia in aspiration pneumonia ~10%)

• Sputum Gram stain + culture (quality specimen; mixed flora suggests oropharyngeal — not helpful; purulent sputum from consolidated segment is better)

• CXR (dependent infiltrates — RLL, RML, posterior segment upper lobes if supine; cavitation → abscess)

• CT chest (characterizes infiltrate, abscess, empyema, obstruction)

• ABG or SpO2 (hypoxia assessment)

• Swallowing evaluation / modified barium swallow (SLP — before oral feeding if aspiration suspected)

• Chest ultrasound (parapneumonic effusion)

Home Meds

• Sedating medications (opioids, benzodiazepines, antipsychotics — reduce gag reflex; assess and minimize)

• ACE inhibitors (cough reflex preserved — some evidence reduces aspiration in stroke patients; continue)

• Antacids/PPIs (reduces acidity of gastric content — modest protection; continue)

• Promotility agents (metoclopramide — reduces gastroparesis; reassess)

Plan

• Aspiration precautions: HOB 30–45°; thickened liquids if dysphagia; NPO if unable to protect airway

• Supplemental O2 to target SpO2 ≥92%

• Aspiration pneumonitis (acute chemical injury — witnessed large aspiration, no fever at onset, pure hypoxia):

  • Supportive care: O2, bronchodilators, monitoring

  • Antibiotics NOT routinely required (sterile injury); observe × 24–48h; start antibiotics only if fever + leukocytosis + infiltrate persisting >24–48h

• Aspiration pneumonia (fever + leukocytosis + consolidation in dependent segment):

  • Community-acquired, outpatient aspiration risk:

    • Amoxicillin-clavulanate 875 mg PO BID × 5–7 days

    • OR Clindamycin 300–450 mg PO TID × 5–7 days (penicillin allergy / anaerobic coverage)

  • Hospitalized aspiration pneumonia:

    • Ampicillin-sulbactam (Unasyn) 3 g IV q6h × 5–7 days

    • Step-down: Amoxicillin-clavulanate 875 mg PO BID when clinically improving

  • Severe aspiration pneumonia / concern for resistant gram-negatives:

    • Cefepime 2 g IV q8h + Metronidazole 500 mg IV/PO q8h

    • If MRSA risk factors: Add Vancomycin (pharmacy dosing)

  • MRSA risk (prior culture, HCAP, nursing home): Add Vancomycin 15–20 mg/kg IV q8–12h

  • Duration: 5–7 days (simple aspiration pneumonia); 14–21 days (abscess or empyema)

• Lung abscess:

  • IV Piperacillin-tazobactam 3.375 g IV q6h OR IV Ampicillin-sulbactam 3 g IV q6h

  • Step-down to PO: Amoxicillin-clavulanate 875 mg PO BID × 4–6 weeks total

  • Postural drainage (physiotherapy)

  • CT-guided drainage or bronchoscopic drainage if >6 cm or not responding to antibiotics

• SLP swallow evaluation before re-initiating oral feeding

• Dental hygiene assessment (reduces bacterial burden)

• Minimize sedating medications; review all medications reducing gag reflex

• Tube feeds (NG or PEG) if unable to safely swallow long-term; head of bed elevation during feeds

• Daily CBC, BMP, procalcitonin; trend fever curve; serial CXR; follow cultures

• Pulmonology consult for severe aspiration pneumonia, abscess, or recurrent events

• PT/OT — mobility; positioning; feeding assistance

• Discharge: Complete antibiotic course; SLP follow-up + dietary modifications; postural precautions; reassess need for PEG tube (long-term aspiration risk); PCP/neurology follow-up for underlying swallow dysfunction; dental referral; education on aspiration risk and positioning

Red Flags

• Massive aspiration → ARDS (bilateral diffuse infiltrates + P/F <300) → ICU; lung-protective ventilation; prone positioning

• Lung abscess >6 cm or not responding to antibiotics at 7–10 days → CT-guided or bronchoscopic drainage + thoracic surgery consult

• Empyema complicating aspiration (pleural effusion + pH <7.2) → chest tube + antibiotics (see empyema section)

• Aspiration in intubated patient (ventilator-associated pneumonia risk) → escalate to HAP/VAP antibiotic coverage; surveillance cultures

• Recurrent aspiration pneumonias in same anatomic distribution → rule out endobronchial obstruction with CT chest + bronchoscopy

Senior IM Resident Pearls

• Pneumonitis vs. pneumonia: Pure pneumonitis = witnessed aspiration + acute hypoxia + bilateral infiltrates + NO fever at 24h; watch and wait; start antibiotics only if fever/leukocytosis/consolidation persists beyond 24–48h (superinfection developing)

• Right lower lobe is the most common aspiration site in upright/semi-recumbent patients (right mainstem bronchus is more vertical); posterior segment of upper lobes in supine patients

• ACE inhibitors reduce aspiration pneumonia in stroke patients — ACE inhibitor-induced cough enhances cough reflex and laryngeal sensitivity; do not routinely stop ACE inhibitor in stroke patients with aspiration risk

• Silent aspiration is common in elderly and stroke patients — no cough reflex; aspiration pneumonia diagnosis requires clinical suspicion based on presentation, risk factors, and dependent lobe infiltrate, not just a witnessed event

• Common mistake: Giving steroids for aspiration pneumonitis — steroids do NOT improve outcomes in aspiration pneumonitis and increase secondary infection risk; antibiotics for bacterial pneumonia only

• Common mistake: Restarting oral feeding without SLP evaluation after aspiration event — always have SLP evaluate before reinstituting oral nutrition; modified barium swallow is the gold standard for aspiration characterization